IDEXX Laboratories Inc
IDXX
$520.31-0.69%
End of day · as of Oct 13, 2026, 8:00 PM ET
Mkt cap
$43.08B
EV/Sales
10.1
P/E ratio
N/A
FY2025 Revenue
$4.30B
EPS (TTM)
$14.23
Gross Margin (FY2025)
61.80%
Profit Margin (FY2025)
24.62%
Beta
N/A
Div yield
N/A
Sector
Healthcare
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported IDXX revenue for 2025-12-31 was $4.30B. Net income was $1.06B. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. IDXX currently screens at market cap $43.08B.
Use this IDXX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IDXX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company in the Healthcare sector.
Latest cached IDEXX Laboratories Inc (IDXX) revenue for Dec 31, 2025 was $4.30B. Net income was $1.06B. Statements: https://lician.com/financials/idxx
IDEXX Laboratories Inc (IDXX) market capitalization is $43.08B on the latest cached snapshot.
IDEXX Laboratories Inc (IDXX) cached previous close $523.94; day range $520.29 – $525.73; volume 445,442. Session quote: https://lician.com/quote/idxx
IDEXX Laboratories Inc (IDXX) latest cached earnings event is "IDXX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IDXX filing is 8-K · Aug 4, 2026. Filings: https://lician.com/sec/idxx